Co-developed Programs

2025 Canadian Thoracic Society Guideline on Alpha-1 Antitrypsin Deficiency

Scientific Planning Committee & Faculty
Paul Hernandez, MDCM, FRCPC (Co-chair)
Darcy Marciniuk, MD, FRCPC, FCAHS, Master FCCP (Co-chair)
Kenneth R. Chapman, MD, MSc, FRCPC, FACP, FCCP, FERS
Erika D. Penz, MSc, SM MD, FRCPC
Yohan Bossé, PhD
François Maltais, MD
Brandie Walker, MD, PhD

Learning Objectives:
At the end of this session, participants will be able to:

Summarize the new recommendations based on evidence, expert clinical remarks and patient perspective of diagnosis and treatment of respiratory disease associated with Alpha-1 Antitrypsin (A1AT) Deficiency
Recognize which populations are most appropriate for targeted testing to improve case-finding of patients at risk of or with documented lung disease associated with A1AT deficiency
Describe the efficacy of A1AT augmentation therapy in patients with COPD and documented A1AT deficiency
Integrate the new recommendations in clinical practice

English webinar March 3, 2025 – Recording
French webinar March 13, 2025 – Recording

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program (MOC) of The Royal College of Physicians and Surgeons of Canada and approved by the Canadian Thoracic Society. You may claim a maximum of 1.5 hours.

This session is co-developed by the Canadian Thoracic Society and Takeda and is planned to achieve scientific integrity, objectivity and balance.

Climate change: Reducing the environmental burden considering the wider context of optimizing the management of respiratory disease

Faculty:
Alan Kaplan, MD CCFP(EM) FCFP CPC(HC)
Jean Bourbeau, MD, MSc, FRCPC, FCAHS
Geneviève Digby, MD, FRCPC, MSc(HQ)

At the end of this session, participants will be able to:

Discuss the impact of climate change on lung health
Understand the importance of shared decision making and factors which should be considered when selecting the most appropriate inhaler device
Implement various actions to maximize the efficacy of your inhaler, while reducing the overall emissions from inhalers

English webinar Nov 18, 2024 – Recording
French webinar Nov 21, 2024 – Recording

This session is co-developed by the Canadian Thoracic Society and Trudell Medical International and is planned to achieve scientific integrity, objectivity and balance.

Developed by Dr. Samir Gupta, Mike Boivin, Dr. Vivien Brown and Dr. George Zhanel, this dynamic presentation covers four key respiratory immunizations – RSV, pneumococcal, influenza, and COVID-19 -providing attendees with up-to-date information on vaccine efficacy, safety profiles, and administration guidelines. Beyond the clinical aspects, they touch on the pressing issues of vaccine hesitancy and fatigue, offering evidence-based approaches to overcome these challenges.

At the end of this session, participants will be able to:

Distinguish between RSV, pneumococcal disease, influenza, and COVID-19 in terms of causative agents, transmission, and general epidemiology
Interpret the current recommendations for each vaccine, including target populations and dosing schedules
Discuss the vaccine effectiveness and safety to allow for a benefit: risk discussion for vaccination
Summarize strategies to address vaccine hesitancy in a patient who is a candidate for respiratory vaccines

English webinar Oct 30, 2024 – Recording
French webinar Nov 4, 2024 – Recording

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program (MOC) of The Royal College of Physicians and Surgeons of Canada and approved bythe Canadian Thoracic Society. Live webinar participants may claim a maximum of 1 hour.

This webinar is for healthcare professionals only, and it was co-developed by the Canadian Thoracic Society and RESPIPLUS.

It received funding from GSK, Merck, Moderna and Pfizer. It is planned to achieve scientific integrity, objectivity and balance.

Severe Asthma Better Action: A Discussion on the Recommendations from the Canadian Delphi Consensus Study

Co-chaired by Dr. Charles Chan and Dr. Andrew O’Keefe, this case-based 90 mins session discusses recommendations from a Canadian Delphi consensus study on best practice for optimal referral and appropriate management of severe asthma.

June 5 2024 (English) – Recording
June 11 2024 (English) – Recording
June 12, 2024 (French) – Recording

Learning objectives:
After attending the session, participants will be able to:

Proactively identify and optimize care for patients with suspected severe asthma
Recognize strategies to assess short-acting beta agonist (SABA) overuse and repeat oral corticosteroid (OCS) therapies for severe asthma management
Support standard and consistent treatment, management, and referral pathways for severe asthma, including biologic therapy selection

This program is co-developed by the Canadian Thoracic Society, Canadian Society of Allergy and Clinical Immunology and AstraZeneca Canada and is planned to achieve scientific integrity, objectivity and balance.

The PHull PHollow-up: Optimizing PAH patient outcomes throughout the patient journey

Presented by PH experts in Canada through five webinars in January-February 2023, this case-based interactive 90-minute program discusses how to optimize PAH patient outcomes.

Presenters:
John Granton MD, FRCPC, University of Toronto, Toronto, ON
Kristina Kemp MD, FRCPC, Dalhousie University, Halifax, NS
Sanjay Mehta MDCM, FRCPC, Western University, London, ON
John Swiston MD, FRCPC, University of British Columbia, Vancouver, BC
Steeve Provencher MD, FRCPC, Université Laval Québec, QC

English webinar, 30 Jan 2023: Recording
French webinar, 27 Feb 2023: Recording

Learning objectives:
At the end of the session, participants will be able to;

Identify patients who are not reaching treatment goals and may benefit from treatment optimization;
Interpret guidelines and data supporting the optimization of treatment strategies;
Integrate evidence and patient preference to set treatment goals and determine optimal treatment strategies; and
Reflect on practice patterns, including virtual patient management, to align with best practices

The program was co-developed by the Canadian Thoracic Society and Janssen and was planned to achieve scientific integrity, objectivity and balance.

Archive:
Past Co-developed Symposia